| Literature DB >> 31427318 |
Vijay S Gc1,2, Marc Suhrcke3,4, Andrew J Atkin5, Esther van Sluijs6, David Turner2.
Abstract
OBJECTIVE: To develop a model to assess the long-term costs and health outcomes of physical activity interventions targeting adolescents.Entities:
Keywords: cost-effectiveness; health economics; physical activity; young adult
Mesh:
Year: 2019 PMID: 31427318 PMCID: PMC6701678 DOI: 10.1136/bmjopen-2018-027566
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Conceptual overview of the model. CHD, coronary heart disease.
Health state utilities and costs used in the model
| Parameter | Value | SE | Distribution | Source |
| Health state utilities |
| |||
| CHD | 0.65 | 0.0203 | Beta (α=357, β=191) | |
| Stroke | 0.52 | 0.0192 | Beta (α=355, β=323) | |
| Heart failure | 0.49 | 0.0194 | Beta (α=326, β=335) | |
| Type 2 diabetes | 0.66 | 0.0054 | Beta (α=5032, β=2548) | |
| Breast cancer | 0.76 | 0.0133 | Beta (α=791, β=256) | |
| Colorectal cancer | 0.67 | 0.0314 | Beta (α=150, β=73) | |
| Costs of health states | ||||
| CHD first event | £5562 | £556 | Gamma (α=100, β=56) |
|
| CHD subsequent | £214 | £21 | Gamma (α=100, β=2) |
|
| CHD fatal | £1458 | £146 | Gamma (α=100, β=15) |
|
| Stroke first event | £10 062 | £1006 | Gamma (α=100, β=101) |
|
| Stroke subsequent | £2705 | £270 | Gamma (α=100, β=27) |
|
| Stroke fatal | £8805 | £881 | Gamma (α=100, β=88) |
|
| HF | £2402 | £240 | Gamma (α=100, β=24) |
|
| HF subsequent | £815 | £82 | Gamma (α=100, β=8) |
|
| Type 2 diabetes | £1257 | £126 | Gamma (α=100, β=13) |
|
| Breast cancer | £12 155 | £1215 | Gamma (α=100, β=122) |
|
| Colorectal cancer | £16 978 | £1698 | Gamma (α=100, β=170) |
|
CHD, coronary heart disease; HF, heart failure.
Baseline utilities associated with physical activity level
| Age-group | Utility values by activity level | Distribution | Source | |||
| Inactive | Low | Moderate | High | |||
| 16–34 | 0.897 | 0.918 | 0.937 | 0.943 | Beta |
|
| 35–44 | 0.770 | 0.889 | 0.914 | 0.927 | Beta |
|
| 45–54 | 0.696 | 0.852 | 0.899 | 0.921 | Beta |
|
| 55–64 | 0.648 | 0.861 | 0.863 | 0.907 | Beta |
|
| 65–74 | 0.657 | 0.823 | 0.870 | 0.897 | Beta |
|
| 65–74 | 0.701 | 0.829 | 0.850 | 0.876 | Beta |
|
Inactive: <30; Low: 30–149; Moderate: 150–420 and High: ≥421 MVPA min per week.
MVPA, moderate-to-vigorous physical activity.
Incremental cost-effectiveness ratios in the base-case and sensitivity analyses
| Total cost (£) | Total QALYs | Incremental cost (£) | Incremental QALY | ICER | |
| Base-case analysis | |||||
| No intervention | 4441 | 21.705 | – | – | – |
| After-school intervention | 4491 | 21.710 | 50.64 | 0.004 | 11 486 |
| Multicomponent intervention | 4629 | 21.712 | 137.89 | 0.002 | 68 056 |
| No (0%) decay of intervention effects | |||||
| No intervention | 4437 | 21.707 | – | – | – |
| After-school intervention | 4451 | 21.898 | 14.32 | 0.191 | 75 |
| Multicomponent intervention | 4571 | 21.987 | 119.59 | 0.089 | 1342 |
| 33% decay of intervention effects | |||||
| No intervention | 4430 | 21.705 | – | – | – |
| After-school intervention | 4479 | 21.718 | 48.86 | 0.013 | 3661 |
| Multicomponent intervention | 4616 | 21.726 | 136.94 | 0.008 | 17 661 |
| 100% decay of intervention effects | |||||
| No intervention | 4432 | 21.705 | – | – | – |
| After-school intervention | 4484 | 21.707 | 51.42 | 0.002 | 28 838 |
| Multicomponent intervention | 4621 | 21.708 | 137.61 | 0.001 | 189 897 |
| Time horizon (10 years) | |||||
| No intervention | 41 | 7.167 | – | – | – |
| After-school intervention | 92 | 7.170 | 51.47 | 0.004 | 14 204 |
| Multicomponent intervention | 231 | 7.172 | 138.60 | 0.002 | 75 100 |
| Time horizon (20 years) | |||||
| No intervention | 219 | 12.835 | – | – | – |
| After-school intervention | 270 | 12.838 | 51.09 | 0.004 | 13 414 |
| Multicomponent intervention | 408 | 12.840 | 138.19 | 0.002 | 72 346 |
ICER, incremental cost-effectiveness ratio (incremental cost/incremental QALY); QALY, quality-adjusted life year.
Figure 2Scatter plot of incremental costs and QALYs for each intervention, relative to no intervention. QALY, quality-adjusted life-year.
Figure 3Cost-effectiveness acceptability curves. QALY, quality-adjusted life-year.